EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Infectious Keratitis Management: 10-Year Update

Neel D Pasricha iD, Pablo Larco iD, Darlene Miller, Diego S Altamirano, Jennifer R Rose-Nussbaumer, Eduardo C Alfonso, Guillermo Amescua iD

Journal of Clinical Medicine · 25.08.2025 · 14 (17) · 5987

DOI: 10.3390/jcm14175987 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.08.2025. Verfasst von Neel D Pasricha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94158, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: All May See Foundation, Research to Prevent Blindness, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infectious keratitis (IK), including bacterial, fungal, parasitic, and viral etiologies, continues to represent a significant cause of ocular morbidity in the United States and around the world. Corneal scraping for smears and cultures remains the gold standard in diagnosing IK; however, molecular diagnoses, including metagenomic deep sequencing (MDS), are promising emerging diagnostic tools. Despite recent interest in procedural treatment such as riboflavin photoactivated chromophore corneal collagen cross-linking (PACK-CXL) and Rose Bengal photodynamic antimicrobial therapy (RB-PDAT), medical treatment advances have remained stagnant.

Methods

This review highlights IK pathogens obtained from corneal cultures at Bascom Palmer Eye Institute (BPEI) from 2011 to 2021 and provides the current BPEI algorithms for initial management of IK or as a referred clinically worsening patient. The roles of corticosteroid therapy, PACK-CXL, and RB-PDAT for IK are also summarized.

Results

A total of 9326 corneal cultures were performed at BPEI between 2011 and 2021, and only 3609 (38.7%) had a positive organism identified, of which bacteria were the most common (83.4%). Fortified vancomycin and tobramycin are recommended as first-line medical therapy for IK patients based on culture sensitivity data for the top Gram-negative (Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus) bacteria. PACK-CXL and RB-PDAT may benefit IK patients with corneal melting and fungal IK, respectively.

Conclusions

Drug holidays, minimizing contamination, and optimizing sample order are crucial to maximizing corneal culture positivity. PACK-CXL and RB-PDAT are promising procedural advancements for IK therapy.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial therapycorneal ulcerinfectious keratitis

Autor:innen und Institutionen

  • Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94158, USA.
  • Francis I. Proctor Foundation, University of California San Francisco, San Francisco, CA 94158, USA.
  • Bascom Palmer Eye Institute, University of Miami, Miami, FL 33136, USA.
  • Instituto Oftalmológico Integral, Santiago 8320214, Chile.
  • Department of Ophthalmology, Stanford University, Palo Alto, CA 94305, USA.

ORCID-Profile: Neel D Pasricha, Pablo Larco, Guillermo Amescua

Förderung

  • All May See Foundation
  • Research to Prevent Blindness
  • NIH HHS
  • NEI NIH HHS
  • National Eye Institute
  • Career Development Award from the Research to Prevent Blindness
  • UCSF Vision Core Grant

Zitieren

APA

Pasricha, N. D., Larco, P., Miller, D., Altamirano, D. S., Rose-Nussbaumer, J. R., Alfonso, E. C., & Amescua, G. (2025). Infectious Keratitis Management: 10-Year Update. Journal of Clinical Medicine, 14(17), 5987. https://doi.org/10.3390/jcm14175987

Vancouver

Pasricha ND, Larco P, Miller D, Altamirano DS, Rose-Nussbaumer JR, Alfonso EC, et al. Infectious Keratitis Management: 10-Year Update. Journal of Clinical Medicine. 2025;14(17):5987. doi:10.3390/jcm14175987

BibTeX
@article{Pasricha2025,
  author = {Pasricha, Neel D and Larco, Pablo and Miller, Darlene and Altamirano, Diego S and Rose-Nussbaumer, Jennifer R and Alfonso, Eduardo C and Amescua, Guillermo},
  title = {Infectious Keratitis Management: 10-Year Update},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {17},
  pages = {5987},
  doi = {10.3390/jcm14175987}
}
Kostenlos starten →